XPH·SPDR S&P Pharmaceuticals ETF

The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and offers investors broad exposure to the Healthcare‑Pharma sector. The fund tracks the S&P Pharmaceuticals Select Industry Index, aiming to match its performance before fees. With assets exceeding $481.8 million, XPH is positioned as a low‑cost, tax‑efficient vehicle for both institutional and retail investors seeking diversified sector exposure.

The State Street SPDR S&P Pharmaceuticals ETF (XPH) debuted in 2006 and offers broad exposure to the healthcare sector through a smart‑beta, non‑cap‑weighted approach. By selecting stocks based on fundamental characteristics and risk‑return potential, XPH seeks to outperform traditional market‑cap weighted peers. The fund’s low expense ratio and transparent methodology make it attractive for investors targeting sector growth while managing volatility. Recent performance has been mixed, reflecting broader healthcare market volatility and regulatory uncertainties.